NCT07715682

Brief Summary

Premature infants frequently experience painful procedures during their admission to neonatal intensive care units; this can lead to acute adverse events, imbalances, and long-term neurodevelopmental implications. This randomized controlled trial evaluates the impact of Gentle Human Touch (GHT) and rate change (eye mask and earplug) on pain and comfort during heel prick blood collection in premature infants (32-36+6 weeks gestational age). A total of 60 infants were randomly assigned to three groups: GHT, rate change, and standard care (pacifier). Pain was assessed using the Premature Infant Pain Profile-Revised (PIPP-R), and comfort was measured before, during, and after the procedure using the COMFORTneo operator. Physiological impact (heart rate, oxygen saturation) and propagation time were recorded. The findings provide evidence for safe and effective non-pharmacological interventions in pain management and their inclusion in developmental care protocols.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
5mo left

Started Apr 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress46%
Apr 2026Dec 2026

First Submitted

Initial submission to the registry

February 19, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

April 20, 2026

Completed
3 months until next milestone

First Posted

Study publicly available on registry

July 20, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

July 20, 2026

Status Verified

September 1, 2025

Enrollment Period

4 months

First QC Date

February 19, 2026

Last Update Submit

July 15, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Procedural Pain Score

    The pain experienced during heel prick blood sampling will be assessed using the Premature Infant Pain Profile-Revised (PIPP-R) scale. The scale ranges from 0 to 21 (for premature infants), with higher scores indicating greater pain intensity.

    5 minutes before the procedure, during the procedure, and 5 minutes after the procedure.

  • Procedural Comfort Score

    Comfort during heel prick blood sampling will be assessed using the COMFORTneo Scale. The scale ranges from 7 to 35, with higher scores indicating a lower level of comfort.

    5 minutes before the procedure, during the procedure, and 5 minutes after the procedure.

Secondary Outcomes (2)

  • Crying Duration

    During and immediately after heel prick blood sampling

  • Oxygen Saturation

    5 minutes before, during, and 5 minutes after heel prick blood sampling

Study Arms (3)

Gentle Human Touch

EXPERIMENTAL

Gentle human touch (GHT) will be applied 3-5 minutes before, during, and after the heel prick blood test.

Other: Gentle Human Touch

Environmental Modification

EXPERIMENTAL

Eye mask and earmuffs will be applied 3-5 minutes before, during, and after the heel prick blood test.

Other: Environmental Modification

Standard Care

NO INTERVENTION

Finger feeding will be provided before, during, and after the procedure, according to the unit routine.

Interventions

Before starting the procedure, the nurse performing the intervention will wear a clean gown and wash both hands and forearms with an antimicrobial agent for 3 minutes. The nurse's hand temperature will be measured with a digital thermometer prior to the intervention to ensure it is at an appropriate level. If the temperature is not suitable, both hands will be warmed under a radiant warmer until they reach 33-33.2 °C, and the intervention will begin once this temperature is achieved. During the intervention, the nurse will place the fingertips of one hand on the infant's eyebrow line with the palm resting on the top of the head, while the other hand will be positioned on the lower abdomen covering the waist and hips, maintaining this position for 15 minutes.

Gentle Human Touch

Infants assigned to the environmental modification group will receive an eye mask and neonatal earmuffs (Minimuffs) to reduce exposure to light and noise. The eye mask is a soft, adjustable, and disposable phototherapy band designed to block external light stimuli. The earmuffs are oval-shaped, foam-based neonatal ear protectors with hydrogel adhesive, designed to reduce noise levels by more than 50% and ensure safe single use. Both interventions will be applied 3-5 minutes before, during, and for 3-5 minutes after venous blood sampling, for a total of approximately 15 minutes. Standard care with a pacifier will also be provided according to unit practice.

Environmental Modification

Eligibility Criteria

Age32 Weeks - 37 Weeks
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Preterm infants with a gestational age between 32 and 36+6 weeks
  • Written informed consent obtained from parents

You may not qualify if:

  • Infants with serious medical conditions that may affect study parameters
  • Infants receiving intensive invasive treatments (e.g., opioid or sedative medication)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Etlik City Hospital

Ankara, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Central Study Contacts

Kubra Nur N KABAKCI SARIDAĞ, RN, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
research assistant

Study Record Dates

First Submitted

February 19, 2026

First Posted

July 20, 2026

Study Start

April 20, 2026

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

July 20, 2026

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations